Abstract
Background
The aim of the present study was to examine the early outcome in patients undergoing intestinal resection for Crohn’s disease (CD) while they are receiving perioperative immunosuppressive medication.
Methods
We reviewed patients with CD undergoing intestinal surgery from 1999 to 2007. Demographics and relevant perioperative information, including medication, were extracted from patient charts. Statistical analysis was performed using Fisher’s exact test.
Results
During the course of the study period 112 with Crohn’s disease underwent intestinal resection, and 69 of them were receiving perioperative medication (47, corticosteroids; 39, immunomodulators; and 17, anti-tumor necrosis factor-α antibodies). There were no deaths. Median blood loss was 137 ml. Twenty-two of the patients using perioperative medication (32%) experienced complications, 10 of which were major. The major complications occurred in 3 of the 43 patients (7%) who were not receiving perioperative medications, in 5 of 38 patients (13%) who were receiving one drug, 4 of 28 patients (14%) receiving two drugs, and 1 of 3 patients (33%) receiving three drugs. Thus the occurrence of major complications was not significantly greater in patients receiving perioperative medication. Risk factors for a major complication were intraoperative blood loss >400 ml (P < 0.003) and emergency surgery (P < 0.005).
Conclusions
The occurrence of complications in Crohn’s disease patients undergoing intestinal resection was not associated with the use of immunosuppressive medication. However, emergency surgery and blood loss were risk factors, and reflect the difficulty of surgery in this group of patients.
Similar content being viewed by others
References
Polle S, Wind J, Ubbink D et al (2006) Short-term outcomes after laparoscopic ileocolic resection for Crohn’s disease. A systematic review. Dig Surg 23:346–357
Hanauer SB (2003) Crohn’s disease: step up or top down therapy. Best Pract Res Clin Gastroenterol 17:131–137
Sandborn W, Sutherland L, Pearson D et al (2000) Azathioprine or 6-mercaptopurine for inducing remission of Crohn’s disease. Cochrane Database Syst Rev 2000:CD000545
Pearson DC, May GR, Fick G et al (2000) Azathioprine for maintaining remission of Crohn’s disease. Cochrane Database Syst Rev 2000:CD000067
Cosnes J, Nion-Larmurier I, Beaugerie L et al (2005) Impact of the increasing use of immunosuppressants in Crohn’s disease on the need for intestinal surgery. Gut 54:237–241
Schluender SJ, Ippoliti A, Dubinsky M et al (2007) Does infliximab influence surgical morbidity of ileal pouch-anal anastomosis in patients with ulcerative colitis? Dis Colon Rectum 50:1747–1753
Selvasekar CR, Cima RR, Larson DW et al (2007) Effect of infliximab on short-term complications in patients undergoing operation for chronic ulcerative colitis. J Am Coll Surg 204:956–962
de Boer MT, Molenaar IQ, Porte RJ (2007) Impact of blood loss on outcome after liver resection. Dig Surg 24:259–264
Colombel JF, Loftus EV Jr, Tremaine WJ et al (2004) Early postoperative complications are not increased in patients with Crohn’s disease treated perioperatively with infliximab or immunosuppressive therapy. Am J Gastroenterol 99:878–883
Yamamoto T, Allan RN, Keighley MR (2000) Risk factors for intra-abdominal sepsis after surgery in Crohn’s disease. Dis Colon Rectum 43:1141–1145
Post S, Betzler M, von Ditfurth B et al (1991) Risks of intestinal anastomoses in Crohn’s disease. Ann Surg 213:37–42
Heimann TM, Greenstein AJ, Mechanic L et al (1985) Early complications following surgical treatment for Crohn’s disease. Ann Surg 201:494–498
Lee RH, Efron DT, Tantry U et al (2000) Inhibition of tumor necrosis factor-alpha attenuates wound breaking strength in rats. Wound Repair Regen 8:547–553
Takesue Y, Ohge H, Uemura K et al (2002) Bacterial translocation in patients with Crohn’s disease undergoing surgery. Dis Colon Rectum 45:1665–1671
Author information
Authors and Affiliations
Corresponding author
Additional information
The abstract of this article was a Poster Presentation at the ASCRS Tripartite Meeting, Boston, Massachusetts, June 2008.
Rights and permissions
About this article
Cite this article
Indar, A.A., Young-Fadok, T.M., Heppell, J. et al. Effect of Perioperative Immunosuppressive Medication on Early Outcome in Crohn’s Disease Patients. World J Surg 33, 1049–1052 (2009). https://doi.org/10.1007/s00268-009-9957-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-009-9957-x